Knoll Capital Management as of Sept. 30, 2018
Portfolio Holdings for Knoll Capital Management
Knoll Capital Management holds 17 positions in its portfolio as reported in the September 2018 quarterly 13F filing
| Company (Ticker) | Portfolio Weight | Valued At | Change in Shares | Share Count | Share Price |
|---|---|---|---|---|---|
| Corbus Pharmaceuticals Hldgs | 25.8 | $31M | 4.1M | 7.50 | |
| Abeona Therapeutics | 25.1 | $30M | 2.4M | 12.56 | |
| Biohaven Pharmaceutical Holding | 23.6 | $28M | 750k | 37.23 | |
| Aldeyra Therapeutics (ALDX) | 5.3 | $6.3M | 484k | 13.05 | |
| Electrocore | 4.8 | $5.7M | 397k | 14.28 | |
| Krystal Biotech (KRYS) | 4.3 | $5.1M | 300k | 17.01 | |
| Galmed Pharmaceuticals | 2.4 | $2.9M | 210k | 13.72 | |
| Entera Bio (ENTX) | 2.0 | $2.4M | 476k | 5.06 | |
| Anavex Life Sciences (AVXL) | 1.6 | $1.9M | 724k | 2.58 | |
| Soligenix | 1.3 | $1.5M | 838k | 1.82 | |
| Vascular Biogenics | 1.3 | $1.5M | 897k | 1.66 | |
| Volitionrx (VNRX) | 0.8 | $916k | 321k | 2.85 | |
| Eiger Biopharmaceuticals | 0.8 | $910k | 75k | 12.09 | |
| Evoke Pharma | 0.7 | $825k | 275k | 3.00 | |
| Chromadex Corp (CDXC) | 0.2 | $192k | 48k | 4.01 | |
| Catasys | 0.1 | $102k | 9.1k | 11.23 | |
| Lipocine | 0.1 | $69k | 50k | 1.38 |
